Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.
Also called NCT05940220
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 130 participants
- Registry
-
NCT05940220
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Iran
- Registry status
- Unknown status
Technical summary
Registry record NCT05940220. Randomized; double masking; primary purpose treatment. Start 2023-12-30 (anticipated); primary completion 2025-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure
- Condition
- Heart Failure
- Intervention (Other)
- Acetazolamide
- Intervention (Other)
- placebo
- Lead sponsor
- Tehran University of Medical Sciences
Record details
- Record id
cardio:ct-nct05940220- Content hash
62344495891ad8d6e9c49f3988d8f52c465734c49dc7e6ac19045f52752b385d